Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure
Status:
Withdrawn
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and to determine the efficacy of D-ribose for the treatment of
congestive heart failure (CHF) in subjects who have been stabilized following hospitalization
with acute decompensation.